Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan G Ni

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
The AAPS Journal|May 1, 2015
Development and Fit-for-Purpose Validation of a Soluble Human Programmed Death-1 Protein AssayYan G Ni, Xiling Yuan, John A Newitt, et al.
The European Journal of Neuroscience|March 26, 2003
Regulation of RGS proteins by chronic morphine in rat locus coeruleusStephen J Gold, Ming-Hu Han, Amy E Herman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentTiffini Voss, Paulette Triglia, Yan G Ni, et al.
Circulation|September 6, 2006
Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signalingYan G Ni, Kambeez Berenji, Na Wang, et al.
The AAPS Journal|October 1, 2025
Why is Biomarker Assay Validation Different from that of Pharmacokinetic Assays?Yan G Ni, Lauren F Stevenson, Lakshmi Amaravadi, et al.
The Journal of Biological Chemistry|February 23, 2010
A proprotein convertase subtilisin-like/kexin type 9 (PCSK9) C-terminal domain antibody antigen-binding fragment inhibits PCSK9 internalization and restores low density lipoprotein uptakeYan G Ni, Jon H Condra, Laura Orsatti, et al.
Journal of Lipid Research|October 21, 2010
A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivoYan G Ni, Stefania Di Marco, Jon H Condra, et al.
International Journal of Biological Sciences|February 23, 2012
An anti-PCSK9 antibody reduces LDL-cholesterol on top of a statin and suppresses hepatocyte SREBP-regulated genesLiwen Zhang, Timothy McCabe, Jon H Condra, et al.
Nature Immunology|January 5, 2021
Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE diseaseAhmet Ozen, Nurhan Kasap, Ivan Vujkovic-Cvijin, et al.
Bioanalysis|December 5, 2015
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3--LBA, biomarkers and immunogenicity)Lakshmi Amaravadi, An Song, Heather Myler, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The AAPS Journal|May 1, 2015
Development and Fit-for-Purpose Validation of a Soluble Human Programmed Death-1 Protein AssayYan G Ni, Xiling Yuan, John A Newitt, et al.
The European Journal of Neuroscience|March 26, 2003
Regulation of RGS proteins by chronic morphine in rat locus coeruleusStephen J Gold, Ming-Hu Han, Amy E Herman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
Drug DevelopmentTiffini Voss, Paulette Triglia, Yan G Ni, et al.
Circulation|September 6, 2006
Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signalingYan G Ni, Kambeez Berenji, Na Wang, et al.
The AAPS Journal|October 1, 2025
Why is Biomarker Assay Validation Different from that of Pharmacokinetic Assays?Yan G Ni, Lauren F Stevenson, Lakshmi Amaravadi, et al.
The Journal of Biological Chemistry|February 23, 2010
A proprotein convertase subtilisin-like/kexin type 9 (PCSK9) C-terminal domain antibody antigen-binding fragment inhibits PCSK9 internalization and restores low density lipoprotein uptakeYan G Ni, Jon H Condra, Laura Orsatti, et al.
Journal of Lipid Research|October 21, 2010
A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivoYan G Ni, Stefania Di Marco, Jon H Condra, et al.
International Journal of Biological Sciences|February 23, 2012
An anti-PCSK9 antibody reduces LDL-cholesterol on top of a statin and suppresses hepatocyte SREBP-regulated genesLiwen Zhang, Timothy McCabe, Jon H Condra, et al.
Nature Immunology|January 5, 2021
Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE diseaseAhmet Ozen, Nurhan Kasap, Ivan Vujkovic-Cvijin, et al.
Bioanalysis|December 5, 2015
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 3--LBA, biomarkers and immunogenicity)Lakshmi Amaravadi, An Song, Heather Myler, et al.
Pageof 2